Logo En IconLogo Mark IconIcelandic Intellectual Property Office

EP3322704

CRYSTALLINE FORM OF N-[(3-AMINO-3-OXETANYL)METHYL]-2-(2,3-DIHYDRO-1,1-DIOXIDO-1,4-BENZOTHIAZEPIN-4(5H)-YL)-6-METHYL-4-QUINAZOLINAMINE FOR THE TREATMENT OF RESPIRATORY SYNCYTIAL VIRUS (RSV) INFECTIONS

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    12.7.2016
  • EP published:
    27.11.2019
  • EP application number:
    16738155.7
  • Max expiry date:
    11.7.2036
  • Title:
    CRYSTALLINE FORM OF N-[(3-AMINO-3-OXETANYL)METHYL]-2-(2,3-DIHYDRO-1,1-DIOXIDO-1,4-BENZOTHIAZEPIN-4(5H)-YL)-6-METHYL-4-QUINAZOLINAMINE FOR THE TREATMENT OF RESPIRATORY SYNCYTIAL VIRUS (RSV) INFECTIONS

Timeline

Today
12.7.2016EP application
27.11.2019EP Publication

Owner

  • Name:
    F. Hoffmann-La Roche AG
  • Address:
    Grenzacherstrasse 124, 4070, Basel, CH

Inventor

  • Name:
    ZHANG, Wei
  • Address:
    Shanghai, CN
  • Name:
    WANG, Lin
  • Address:
    Shanghai, CN
  • Name:
    LI, Wei
  • Address:
    Shanghai, CN

Priority

  • Number:
    PCT/CN2015/084225
  • Date:
    16.7.2015
  • Country:
    WO

Classification

  • Categories:
    C07D 417/04, C07D 417/14, A61K 31/5415, A61P 31/12, A61P 31/14

Upload documents